newsfilter
← Latest News
GlobeNewswire·

89bio to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver